HAROLD O. CONN, M.D.; RAYMOND YESNER, M.D.
Percutaneous liver biopsy has been demonstrated to be a valuable tool in the diagnosis of metastatic cancer of the liver (1-7). The frequency with which a single liver biopsy demonstrates metastatic cancer in patients proved to have hepatic metastases has been reported to range from 66 (3) to 91 per cent (2) and averages 71 per cent (Table 1). These studies, in which most of the patients have shown obvious signs of metastatic disease of the liver, may have exaggerated its true value. It has been widely stated that the presence of hepatic metastases can be detected by a single
CONN HO, YESNER R. A Re-evaluation of Needle Biopsy in the Diagnosis of Metastatic Cancer of the Liver. Ann Intern Med. 1963;59:53–61. doi: https://doi.org/10.7326/0003-4819-59-1-53
Download citation file:
Published: Ann Intern Med. 1963;59(1_Part_1):53-61.
Gastroenterology/Hepatology, Liver Disease.
Results provided by:
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use